Poland· PL-100517109
Datroway
A other monoclonal antibodies and antibody drug conjugates product containing datopotamabum deruxtecanum, registered in Poland by Daiichi Sankyo Europe GmbH. The same ATC class is registered in 5 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Datopotamabum deruxtecanum is registered in 5 of 19 countries.
Countries holding a registration under ATC L01FX (other monoclonal antibodies and antibody drug conjugates), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 4 of them publish a price we can compare per daily dose
Datopotamabum deruxtecanum · ATC L01FX
5 / 19 countries
- Finlandprice
- Icelandprice
- Netherlands
- Polandprice
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Datopotamabum deruxtecanum
- Manufacturer
- Daiichi Sankyo Europe GmbH
- Country
- Poland (PL)
- ATC code
- L01FX
- ATC class
- Other monoclonal antibodies and antibody drug conjugates
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin04260161044039
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Datopotamabum deruxtecanum in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumDatroway 100 mgDaiichi Sankyo Europe
- SwitzerlandDATROWAY 100 mg, Pulver für ein Konzentrat zur Herstellung einer InfusionslösungDaiichi Sankyo (Schweiz) AG
- CzechiaDATROWAYDaiichi Sankyo Europe GmbH, Mnichov
- SpainDATROWAY 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONDaiichi Sankyo Europe Gmbh
- FinlandDatrowayDaiichi Sankyo Europe GmbH
- IrelandDatroway 100 mg powder for concentrate for solution for infusionDaiichi Sankyo Europe GmbH
- IcelandDatrowayDAIICHI SANKYO EUROPE GmbH*
- SwedenDatroway 100 mg Pulver till koncentrat till infusionsvätska, lösningDaiichi Sankyo Europe GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Datroway
- Liechtenstein · Datroway
- Norway · Datroway
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a4c65bff-3f99-4010-be26-2b70ea36c3b7 GET /v1/drugs/a4c65bff-3f99-4010-be26-2b70ea36c3b7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek do sporządzania koncentratu roztworu do infuzji",
"source": "urpl",
"strength": "100 mg",
"packaging": "04260161044039 ¦ Rpz ¦ EU/1/25/1915/001 ¦ 161534\n1 fiol. 100 mg proszku",
"substance": "Datopotamabum deruxtecanum 100 mg",
"common_name": "Datopotamabum deruxtecanum",
"pl_product_id": "100517109",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about datopotamabum deruxtecanum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.